{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:09:03Z","timestamp":1791007743802,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007022","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T00:00:00Z","timestamp":1276646400000}}],"reference-count":151,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007022.pub2","type":"journal-article","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T15:57:15Z","timestamp":1276617435000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Teicoplanin versus vancomycin for proven or suspected infection"],"prefix":"10.1002","author":[{"given":"Alexandre B","family":"Cavalcanti","sequence":"first","affiliation":[{"name":"Hospital do Cora\u00e7\u00e3o; Education and Research Institute; Rua Ab\u00edlio Soares, 250 12 Andar S\u00e3o Paulo SP Brazil 04005-909"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson R","family":"Goncalves","sequence":"additional","affiliation":[{"name":"Univille - Universidade da Regiao de Joinville; Departamento de Medicina; Rua Ex-Combatentes Joinville SC Brazil 125\/7A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia S","family":"Almeida","sequence":"additional","affiliation":[{"name":"Universidade de Sao Paulo; Medical School; Rua Beta, 181 Sao Paulo SP Brazil 04249090"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo DG","family":"Bugano","sequence":"additional","affiliation":[{"name":"Universidade de Sao Paulo; Medical School; Rua Beta, 181 Sao Paulo SP Brazil 04249090"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Silva","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein; Intensive Care Unit; Rua Corinto, 65, Vila de Sao Fernando Cotia S\u00e3o Paulo SP Brazil 06705-535"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,16]]},"reference":[{"issue":"Spec. Iss. Nov","key":"10.1002\/14651858.CD007022.pub2-BIB0001|cit1","first-page":"984","article-title":"Teicoplanin or vancomycin in febrile neutropenic children with cancer: A randomized study on cost effectiveness","volume":"27","author":"Auperin","year":"1997","journal-title":"Medecine et Maladies Infectieuses"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007022.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/BF01713981","article-title":"Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram-positive infections in intensive care patients","volume":"20","author":"Charbonneau","year":"1994","journal-title":"Intensive Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0003|cit3","first-page":"165","article-title":"A randomized study comparing clinical efficacy of ceftazidime plus aztreonam plus teicoplanin or vancomycin containing regimen in febrile granulocytopenic patients","volume":"10","author":"Choi","year":"1992","journal-title":"Journal of the Korean Society of Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0609.1993.tb01901.x","article-title":"Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients","volume":"54","author":"Chow","year":"1993","journal-title":"European Journal of Haematology. Supplementum"},{"issue":"9","key":"10.1002\/14651858.CD007022.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1128\/AAC.34.9.1642","article-title":"Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients","volume":"34","author":"Kureishi","year":"1990","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"11","key":"10.1002\/14651858.CD007022.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1128\/AAC.35.11.2246","article-title":"Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity","volume":"35","author":"Kureishi","year":"1991","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007022.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.1990.tb07934.x","article-title":"A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients","volume":"76","author":"Cony-Makhoul","year":"1990","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000077807","article-title":"Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation","volume":"50","author":"D'Antonio","year":"2004","journal-title":"Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD007022.pub2-BIB0009|cit9","first-page":"515","article-title":"[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes]","volume":"196","author":"Figuera","year":"1996","journal-title":"Revista Clinica Espanola"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0010|cit10","first-page":"162","article-title":"Empiric antibiotic regimen for febrile neutropenia (FN). Imipenem plus vancomycin vs imipenem plus teicoplanin as initial therapy [abstract]","volume":"15","author":"Hernandez","year":"1995","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/320869","article-title":"Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin","volume":"33","author":"Fortun","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0012|cit12","unstructured":"Hedstr\u00f6m SA Teicoplanin vs vancomycin in severe Gram-positive infection - a multicentre Scandinavian trial [abstract] 7th European Congress of Clinical Microbiology and Infectious Diseases; 1995 March; Vienna, Austria 1995 232"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00044011-199612020-00003","article-title":"Comparative study of teicoplanin vs vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia","volume":"12","author":"Liu","year":"1996","journal-title":"Clinical Drug Investigation"},{"issue":"9","key":"10.1002\/14651858.CD007022.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1128\/AAC.38.9.2041","article-title":"Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program","volume":"38","author":"Menichetti","year":"1994","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0016|cit15","unstructured":"Marion Merrel Dow - USA Protocol 009 Data on file, Marion Merrell Dow"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0015|cit16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/AAC.35.1.79","article-title":"Failure of treatment with teicoplanin at 6 milligrams\/kilogram\/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon","volume":"35","author":"Gilbert","year":"1991","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0017|cit17","unstructured":"Marion Merrel Dow - USA Protocol 014 Data on file, Marion Merrell Dow"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0018|cit18","unstructured":"Marion Merrell Dow - USA Protocol 019 Data on file, Marion Merrell Dow"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0924-8579(95)00002-P","article-title":"Teicoplanin vs vancomycin for the treatment of serious infections: A randomised trial","volume":"5","author":"Neville","year":"1995","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0020|cit20","first-page":"1205","article-title":"Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients","volume":"5","author":"Nucci","year":"1998","journal-title":"Oncology Reports"},{"issue":"7","key":"10.1002\/14651858.CD007022.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0369-8114(01)00203-6","article-title":"The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci","volume":"49","author":"Pham Dang","year":"2001","journal-title":"Pathologie Biologie"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/169.2.350","article-title":"A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer","volume":"169","author":"Rolston","year":"1994","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s101560050037","article-title":"Prospective, double-blind, randomized trial of teicoplanin versus vancomycin for the therapy of vascular access-associated bacteremia caused by gram-positive pathogens","volume":"5","author":"Rolston","year":"1999","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1179\/joc.2000.12.4.326","article-title":"Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia","volume":"12","author":"Sidi","year":"2000","journal-title":"Journal of Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD007022.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.33.8.1193","article-title":"Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters","volume":"33","author":"Smith","year":"1989","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0026|cit26","unstructured":"Gerard M Van der Auwera P Meunier F A controlled clinical trial on efficacy and safety of teicoplanin(T) versus vancomycin (V) in the treatment of staphylococcal infections [abstract] 27th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1987 Oct 5-7; Washington, DC 1987 278"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.35.3.451","article-title":"Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts","volume":"35","author":"Auwera","year":"1991","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"Suppl A","key":"10.1002\/14651858.CD007022.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/21.suppl_A.81","article-title":"Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results","volume":"21","author":"Laethem","year":"1988","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0029|cit29","first-page":"231","article-title":"Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients","volume":"84","author":"Vazquez","year":"1999","journal-title":"Haematologica"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0924-8579(00)00123-0","article-title":"Comparative pharmacoeconomic study of vancomycin and teicoplanin in intensive care patients","volume":"15","author":"Abad","year":"2000","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1-3","key":"10.1002\/14651858.CD007022.pub2-BIB0031|cit31","first-page":"141","article-title":"[Infective endocarditis treated with glycopeptides. Report of 17 cases]","volume":"38","author":"Adinolfi","year":"1991","journal-title":"Giornale Italiano di Chemioterapia"},{"issue":"7","key":"10.1002\/14651858.CD007022.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.burns.2004.03.005","article-title":"The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients","volume":"30","author":"Altoparlak","year":"2004","journal-title":"Burns"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijantimicag.2004.12.005","article-title":"Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases","volume":"25","author":"Arda","year":"2005","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"37","key":"10.1002\/14651858.CD007022.pub2-BIB0034|cit34","first-page":"1950","article-title":"[Treatment of infection in granulopenic patients. Lessons from international studies]","volume":"17","author":"Beytout","year":"1988","journal-title":"Presse Medicale"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD007022.pub2-BIB0035|cit35","first-page":"389","article-title":"Evaluation of spontaneous resistance to glycopeptide antibiotics in staphylococcal populations","volume":"1","author":"Biavasco","year":"1989","journal-title":"Journal of Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/503400","article-title":"Glycopeptide resistance in Staphylococcus haemolyticus during treatment with teicoplanin","volume":"22","author":"Blans","year":"2001","journal-title":"Infection Control and Hospital Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/infdis\/170.5.1344","article-title":"Vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer","volume":"170","author":"Borja","year":"1994","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/adc.70.6.484","article-title":"Once daily antibiotic regimen in paediatric oncology","volume":"70","author":"Bouffet","year":"1994","journal-title":"Archives of Disease in Childhood"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007022.pub2-BIB0039|cit39","first-page":"52","article-title":"[Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci]","volume":"197","author":"Bouza","year":"1997","journal-title":"Revista Clinica Espanola"},{"issue":"Suppl A","key":"10.1002\/14651858.CD007022.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/21.suppl_A.133","article-title":"Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis","volume":"21","author":"Bowley","year":"1988","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004610.pub2","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhea in adults","author":"Bricker","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF02013463","article-title":"Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis","volume":"5","author":"Brumfitt","year":"1986","journal-title":"European Journal of Clinical Microbiology"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01963643","article-title":"Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin","volume":"9","author":"Brunet","year":"1990","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00019053-199915010-00006","article-title":"Cost analysis of 2 empiric antibacterial regimens containing glycopeptides for the treatment of febrile neutropenia in patients with acute leukaemia","volume":"15","author":"Bucaneve","year":"1999","journal-title":"Pharmacoeconomics"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007022.pub2-BIB0045|cit45","first-page":"22","article-title":"Enterococcal resistance to glycopeptide antibiotics","volume":"195","author":"Cercendado Mansilla","year":"1995","journal-title":"Revista Clinica Espanola"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/jinf.2000.0651","article-title":"Glycopeptide resistance in Staphylococcus aureus","volume":"40","author":"Chadwick","year":"2000","journal-title":"Journal of Infection"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/jac\/25.4.716-a","article-title":"The potential impact on clinical practice of differences in the in-vitro activity of vancomycin and teicoplanin","volume":"25","author":"Cheesbrough","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD007022.pub2-BIB0048|cit48","first-page":"600","article-title":"Vancomycin and teicoplanin: differential aspects","volume":"13","author":"Cobo","year":"1995","journal-title":"Enfermedades Infecciosas y Microbiologia Clinica"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jac\/38.6.1113","article-title":"The comparative efficacy and safety of teicoplanin and vancomycin","volume":"38","author":"Cobo","year":"1996","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007022.pub2-BIB0050|cit50","first-page":"54","article-title":"Vancomycin and teicoplanin use as antibiotic prophylaxis in cardiac surgery: pharmacoeconomic study","volume":"114","author":"Codina","year":"2000","journal-title":"Medicina Clinica"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007022.pub2-BIB0051|cit51","first-page":"S12","article-title":"Glycopeptides in the treatment of staphylococcal infections","volume":"14","author":"Daschner","year":"1995","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jac\/37.3.623","article-title":"Impact of glycopeptide therapy after hospital discharge on inpatient costs: a comparison of teicoplanin and vancomycin","volume":"37","author":"Davey","year":"1996","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD007022.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/AAC.33.7.1125","article-title":"Treatment of Clostridium difficile-associated disease with teicoplanin","volume":"33","author":"Lalla","year":"1989","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD007022.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.36.10.2192","article-title":"Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea","volume":"36","author":"Lalla","year":"1992","journal-title":"Antimicrobial Agents & Chemotherapy."},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/infdis\/154.2.349","article-title":"Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance","volume":"154","author":"Bene","year":"1986","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD007022.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/AAC.39.8.1842","article-title":"Protein binding and serum bactericidal activities of vancomycin and teicoplanin","volume":"39","author":"Dykhuizen","year":"1995","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10006-005-0645-1","article-title":"[Soft tissue infections in oral, maxillofacial, and plastic surgery. Bacterial spectra and antibiotics]","volume":"9","author":"Eckert","year":"2005","journal-title":"Mund-, Kiefer- und Gesichtschirurgie"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s005200050272","article-title":"Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support","volume":"7","author":"Egerer","year":"1999","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jac\/20.4.609","article-title":"The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci","volume":"20","author":"Felmingham","year":"1987","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0195-6701(86)90008-3","article-title":"The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms","volume":"7 Suppl A","author":"Fietta","year":"1986","journal-title":"Journal of Hospital Infection"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"ii5","DOI":"10.1093\/jac\/dki004","article-title":"Safety and efficacy of glycopeptide antibiotics","volume":"55 Suppl 2","author":"Finch","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0062|cit62","first-page":"68","article-title":"[Pharmacological considerations in the economic evaluation of glycopeptides]","volume":"197 Suppl 2","author":"Garcia-Quetglas","year":"1997","journal-title":"Revista Clinica Espanola"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1586\/14789072.2.6.845","article-title":"Dalbavancin: an investigational glycopeptide","volume":"2","author":"Guay","year":"2004","journal-title":"Expert Review of Antiinfective Therapy"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jac\/48.1.53","article-title":"Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems","volume":"48","author":"Hallgren","year":"2001","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0163-4453(93)92416-T","article-title":"Glycopeptide sensitivity of staphylococci","volume":"27","author":"Haverkorn","year":"1993","journal-title":"Journal of Infection"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0934-8840(11)80711-5","article-title":"Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods","volume":"282","author":"Jansen","year":"1995","journal-title":"Zentralblatt fur Bakteriologie"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0067|cit67","first-page":"208","article-title":"Proteinuria in VLBW-premature babies under Teicoplanin and Vancomycin therapy","volume":"143","author":"Jensen","year":"1995","journal-title":"Monatsschrift fur Kinderheilkunde"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0068|cit68","first-page":"296","article-title":"Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin\/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie","volume":"11","author":"Klaus","year":"1995","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jac\/31.2.323","article-title":"Antistaphylococcal activity of vancomycin and teicoplanin under anaerobic conditions","volume":"31","author":"Knowles","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1525-1594.1992.tb00323.x","article-title":"Pharmacokinetics and dosage adjustment of antibiotics during continuous extracorporeal lung assistance and hemofiltration","volume":"16","author":"Kroh","year":"1992","journal-title":"Artificial Organs"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jac\/18.4.513","article-title":"Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin","volume":"18","author":"Lagast","year":"1986","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0072|cit72","first-page":"3","article-title":"[Teicoplanin. New treatment potentials for gram-positive infections in the hospital]","volume":"44","author":"Lakovlev","year":"1999","journal-title":"Antibiotiki i Khimioterapiia"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jac\/38.6.1091","article-title":"Bolus or infusion teicoplanin for intravascular catheter associated infections in immunocompromised patients?","volume":"38","author":"Ley","year":"1996","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD007022.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2169\/naika.79.1663","article-title":"[Drug therapy of intractable methicillin-resistant staphylococcal infections]","volume":"79","author":"Matsumoto","year":"1990","journal-title":"Nippon Naika Gakkai Zasshi"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jac\/42.2.189","article-title":"Glycopeptide tolerance in Staphylococcus aureus","volume":"42","author":"May","year":"1998","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/10428199209058684","article-title":"The use of glycopeptides as empiric antibiotic therapy in febrile neutropenic patients. A comparison between Teicoplanin (TEI) and Vancomycin (VAN). The GIMEMA-Infection Program","volume":"7 Suppl 2","author":"Favero","year":"1992","journal-title":"Leukemia and Lymphoma"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/29.4.461","article-title":"Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice","volume":"29","author":"Menichetti","year":"1992","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1515\/jpme.1997.25.4.361","article-title":"Comparison of vancomycin and teicoplanin for prophylaxis of sepsis with coagulase negative staphylococci (CONS) in very low birth weight (VLBW) infants","volume":"25","author":"Moller","year":"1997","journal-title":"Journal of Perinatal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/MO:19:3:161","article-title":"Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia","volume":"19","author":"Montalar","year":"2002","journal-title":"Medical Oncology"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"S450","DOI":"10.1177\/089686089901902S74","article-title":"Treatment of peritonitis in pediatric continuous peritoneal dialysis","volume":"19 Suppl 2","author":"Muller-Wiefel","year":"1999","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0082|cit82","first-page":"38","article-title":"Infections caused by beta-lactam resistant staphylococci on joint prostheses: diagnosis and treatment","volume":"197 Suppl 2","author":"Munoz","year":"1997","journal-title":"Revista Clinica Espanola"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1179\/joc.1998.10.3.266","article-title":"A closer look at vancomycin, teicoplanin and antimicrobial resistance","volume":"10","author":"Nathwani","year":"1998","journal-title":"Journal of Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jac\/11.1.94","article-title":"Antibacterial activity of teichomycin, a new glycopeptide antibiotic, in comparison to vancomycin","volume":"11","author":"Peters","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD007022.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2165\/00019053-200523090-00006","article-title":"Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections","volume":"23","author":"Plosker","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1002\/14651858.CD007022.pub2-BIB0086|cit86","first-page":"661","article-title":"A study of the possible interactions between human platelets and the antibiotic MDL-507 (teicoplanin)","volume":"24","author":"Porta","year":"1986","journal-title":"International Journal of Clinical Pharmacology, Therapy and Toxicology"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0087|cit87","first-page":"65","article-title":"[Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.]","volume":"19","author":"Portoles","year":"2006","journal-title":"Revista Espanola de Quimioterapia"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5694\/j.1326-5377.1999.tb123561.x","article-title":"Vancomycin and teicoplanin use in Victorian hospitals. The Victorian Drug Usage Evaluation Group","volume":"171","author":"Robertson","year":"1999","journal-title":"Medical Journal of Australia"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.36.6.1204","article-title":"Absence of \"red man syndrome\" in patients being treated with vancomycin or high-dose teicoplanin","volume":"36","author":"Rybak","year":"1992","journal-title":"Antimicrobial Agents & Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0090|cit90","first-page":"28","article-title":"Teicoplanin vs vancomycin: cost-effectiveness comparisons","volume":"28 Suppl 1","author":"Rybak","year":"1993","journal-title":"Hospital Formulary"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/AAC.34.5.765","article-title":"Comparison of vancomycin- and teicoplanin-induced histamine release and \"red man syndrome\"","volume":"34","author":"Sahai","year":"1990","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0092|cit92","first-page":"372","article-title":"Teicoplanin","volume":"38","author":"Salaria","year":"2001","journal-title":"Indian Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1681\/ASN.V101136","article-title":"Intermittent versus continuous intraperitoneal glycopeptide\/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS)","volume":"10","author":"Schaefer","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0094|cit94","first-page":"20","article-title":"Cost effectiveness of teicoplanin and ceftriaxone: a once-daily antibiotic regimen","volume":"28 Suppl 1","author":"Schaison","year":"1993","journal-title":"Hospital Formulary"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jac\/41.2.311","article-title":"Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus","volume":"41","author":"Schmitz","year":"1998","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s15010-002-2117-y","article-title":"Combination of quinupristin\/dalfopristin and glycopeptide in severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens","volume":"30","author":"Scotton","year":"2002","journal-title":"Infection"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0163-4453(94)94564-0","article-title":"Success of teicoplanin over vancomycin in streptococcal endocarditis","volume":"28","author":"Sheikh","year":"1994","journal-title":"Journal of Infection"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/infdis\/159.6.1132","article-title":"Activity of various glycopeptides against an inducibly vancomycin-resistant strain of Enterococcus faecium (D366)","volume":"159","author":"Shlaes","year":"1989","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/clinids\/20.4.1071","article-title":"Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin","volume":"20","author":"Shlaes","year":"1995","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/j.1875-9114.1994.tb02786.x","article-title":"Effect of human serum on killing activity of vancomycin and teicoplanin against Staphylococcus aureus","volume":"14","author":"Stanley","year":"1994","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0101|cit101","first-page":"26","article-title":"Clinical and epidemiologic analysis of intestinal tract colonization with vancomycin-resistant enterococci in an intensive care unit","volume":"37","author":"Togneri","year":"2005","journal-title":"Revista Argentina de Microbiologia"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3201\/eid0805.010387","article-title":"Emergence of vancomycin-intermediate Staphylococcus aureus and S. sciuri, Greece","volume":"8","author":"Tsakris","year":"2002","journal-title":"Emerging Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.coph.2004.04.006","article-title":"Glycopeptides in clinical development: pharmacological profile and clinical perspectives","volume":"4","author":"Bambeke","year":"2004","journal-title":"Current Opinion in Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jac\/19.5.623","article-title":"Bactericidal activity and killing rate of serum in volunteers receiving vancomycin or teicoplanin with and without amikacin given intravenously","volume":"19","author":"Auwera","year":"1987","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/infdis\/173.5.1129","article-title":"Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci","volume":"173","author":"Auwera","year":"1996","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD007022.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/00007611-199308000-00009","article-title":"Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial","volume":"86","author":"Weinberg","year":"1993","journal-title":"Southern Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","article-title":"Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea","volume":"22","author":"Wenisch","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"8871","key":"10.1002\/14651858.CD007022.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0140-6736(93)91440-W","article-title":"Vancomycin-resistant enterococci","volume":"342","author":"Wilcox","year":"1993","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jac\/14.5.441","article-title":"Teicoplanin","volume":"14","author":"Williams","year":"1984","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jac\/37.2.209","article-title":"The comparative efficacy and safety of teicoplanin and vancomycin","volume":"37","author":"Wood","year":"1996","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/1120009X.2000.11782314","article-title":"Comparative safety of teicoplanin and vancomycin","volume":"12 Suppl 5","author":"Wood","year":"2000","journal-title":"Journal of Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0112|cit112","first-page":"913","article-title":"A randomized controlled clinical trial of teicoplanin versus vancomycin in the treatment of severe gram-positive bacterial infections","volume":"29","author":"Zhao","year":"2003","journal-title":"Jiangsu Medicine Journal"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0113|cit113","unstructured":"Akan H Comparison of Teicoplanin and Vancomycin in terms of efficacy and side effect profile during initial antibiotic treatment of febrile neutropenic patients at high risk for gram positive infection: multi-center, prospective, randomized study http:\/\/www.clinicalstudyresults.org\/documents\/company-study_8797_0.pdf 2009"},{"issue":"7382","key":"10.1002\/14651858.CD007022.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0115|cit115","first-page":"376","article-title":"Vancomycin ototoxicity and nephrotoxicity. A review","volume":"3","author":"Bailie","year":"1988","journal-title":"Medical Toxicology & Adverse Drug Experience"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/AAC.34.1.139","article-title":"Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats","volume":"34","author":"Beauchamp","year":"1990","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD007022.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/AAC.36.10.2204","article-title":"Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling","volume":"36","author":"Beauchamp","year":"1992","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Critical Care"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1542\/peds.103.4.e48","article-title":"Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study","volume":"103","author":"Bhatt-Mehta","year":"1999","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijantimicag.2008.05.012","article-title":"Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis","volume":"32","author":"Brink","year":"2008","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/216507990705500504","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: an ever-emerging epidemic","volume":"55","author":"Bubacz","year":"2007","journal-title":"AAOHN Journal"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/j.1875-9114.1986.tb03471.x","article-title":"Vancomycin: an update","volume":"6","author":"Cheung","year":"1986","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/159.5.938","article-title":"Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography","volume":"159","author":"Cremieux","year":"1989","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Simonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"8","key":"10.1002\/14651858.CD007022.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/archinte.1989.00390080053013","article-title":"Mild nephrotoxicity associated with vancomycin use","volume":"149","author":"Downs","year":"1989","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0126|cit126","first-page":"103","article-title":"Vancomycin toxicity. What is the evidence for dose dependency?","volume":"13","author":"Duffull","year":"1994","journal-title":"Adverse Drug Reactions & Toxicological Reviews"},{"issue":"7109","key":"10.1002\/14651858.CD007022.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007022.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"ii5","DOI":"10.1093\/jac\/dki004","article-title":"Safety and efficacy of glycopeptide antibiotics","volume":"55","author":"Finch","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7454","key":"10.1002\/14651858.CD007022.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"issue":"19","key":"10.1002\/14651858.CD007022.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD007022.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00075198-200212000-00005","article-title":"Developing a consensus classification system for acute renal failure","volume":"8","author":"Kellum","year":"2002","journal-title":"Current Opinion in Critical Care"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1179\/joc.1997.9.6.420","article-title":"Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?","volume":"9","author":"Kralovicova","year":"1997","journal-title":"Journal of Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0134|cit134","doi-asserted-by":"crossref","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184.ch6"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1345\/aph.1H414","article-title":"Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus","volume":"41","author":"Maclayton","year":"2007","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0136|cit136","doi-asserted-by":"crossref","unstructured":"Mehta RL Kellum JA Shah SV Molitoris BA Ronco C Warnock DG Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury Critical Care 2007 R31 17331245","DOI":"10.1186\/cc5713"},{"issue":"8","key":"10.1002\/14651858.CD007022.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","author":"National Nosocomial Infections Surveillance System","year":"2004","journal-title":"American Journal of Infection Control"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0138|cit138","unstructured":"Willis NS Mitchell R Higgins GY Craig JC Cochrane Renal Group About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2010, Issue 3. Art. No.: RENAL (accessed April 2010)"},{"issue":"6","key":"10.1002\/14651858.CD007022.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1086\/516664","article-title":"Acquisition of methicillin-resistant Staphylococcus aureus in the acute care setting: incidence and risk factors","volume":"28","author":"Rioux","year":"2007","journal-title":"Infection Control and Hospital Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD007022.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone and with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-3565(25)20414-1","article-title":"Mechanism of vancomycin transport in the kidney: studies in rabbit renal brush border and basolateral membrane vesicles","volume":"259","author":"Sokol","year":"1991","journal-title":"Journal of Pharmacology & Experimental Therapeutics"},{"issue":"20","key":"10.1002\/14651858.CD007022.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods","volume":"18","author":"Thompson","year":"1999","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0143|cit143","first-page":"231","article-title":"Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients","volume":"84","author":"Vazquez","year":"1999","journal-title":"Haematologica"},{"issue":"1","key":"10.1002\/14651858.CD007022.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02026127","article-title":"Methicillin-resistant Staphylococcus aureus in Europe","volume":"13","author":"Voss","year":"1994","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD007022.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","article-title":"Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea","volume":"22","author":"Wenisch","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD007022.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/sim.4780101105","article-title":"A general parametric approach to the meta-analysis of randomized clinical trials","volume":"10","author":"Whitehead","year":"1991","journal-title":"Statistics in Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007022.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0924-8579(94)90049-3","article-title":"A critical review of the dosage of teicoplanin in Europe and the USA","volume":"4","author":"Wilson","year":"1994","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"3","key":"10.1002\/14651858.CD007022.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jac\/37.2.209","article-title":"The comparative efficacy and safety of teicoplanin and vancomycin","volume":"37","author":"Wood","year":"1996","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD007022.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/1120009X.2000.11782314","article-title":"Comparative safety of teicoplanin and vancomycin","volume":"12 Suppl 5","author":"Wood","year":"2000","journal-title":"Journal of Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD007022.pub2-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007022","article-title":"Teicoplanin versus vancomycin for proven or suspected infection","author":"Cavalcanti","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007022.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:06:24Z","timestamp":1740182784000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007022.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,16]]},"references-count":151,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007022.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,16]]}}}